Distinct contributions of different CD40 TRAF binding sites to CD154-induced dendritic cell maturation and IL-12 secretion

European Journal of Immunology

Volumn 33, Issue 3, 2003, Pages 779-789

  Mackey, Matthew F ^a,b   Wang, Ze ^a   Eichelberg, Katrin ^a   Germain, Ronald N ^a  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

^b SANOFI   (France)

Author keywords

CD40; Cytokine; Dendritic cell; Signal transduction; TRAF

Indexed keywords

ADAPTOR PROTEIN; CD40 ANTIGEN; CD40 LIGAND; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 12; JANUS KINASE; PROTEIN P40; RECEPTOR PROTEIN; SYNAPTOPHYSIN; TUMOR NECROSIS FACTOR RECEPTOR; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR 2; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR 3; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR 5; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR 6; UNCLASSIFIED DRUG;

ANIMAL CELL; ANTIGEN PRESENTATION; BINDING SITE; BONE MARROW CELL; CELL FUNCTION; CELL MATURATION; CELL TYPE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; CYTOPLASM; DENDRITIC CELL; ENZYME ACTIVATION; IMMUNOREGULATION; IMMUNOSTIMULATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DOMAIN; PROTEIN SECRETION; RETROVIRUS; REVIEW; SIGNAL TRANSDUCTION; VIRUS GENE;

AMINO ACID SEQUENCE; ANIMALS; ANTIGENS, CD40; BINDING SITES; CARRIER PROTEINS; CD40 LIGAND; DENDRITIC CELLS; HUMANS; INTERLEUKIN-12; MICE; MICE, INBRED BALB C; MITOGEN-ACTIVATED PROTEIN KINASES; MOLECULAR SEQUENCE DATA; NF-KAPPA B; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PROTEINS; TNF RECEPTOR-ASSOCIATED FACTOR 6;

EID: 0037352072     PISSN: 00142980     EISSN: None     Source Type: Journal    
DOI: 10.1002/eji.200323729     Document Type: Review

References (49)

1. Banchereau, J. and Steinman, R. M., Dendritic cells and the control of immunity. Nature 1998. 392: 245-252.
2. Reis e Sousa, C., Dendritic cells as sensors of infection. Immunity 2001. 14: 495-498.
3. Ding, L. and Shevach, E. M., Differential effects of CD28 engagement and IL-12 on T cell activation by altered peptide ligands. J. Immunol 1998. 161: 6614-6621.
4. Ruedl, C., Bachmann, M. F. and Kopf, M., The antigen dose determines T helper subset development by regulation of CD40 ligand. Eur. J. Immunol. 2000. 30: 2056-2064.
5. Caux, C., Massacrier, C., Vanbervliet, B., Dubois, B., Van Kooten, C., Durand, I. and Banchereau, J., Activation of human dendritic cells through CD40 cross-linking. J. Exp. Med. 1994. 180: 1263-1272.
6. Aicher, A., Shu, G. L., Magaletti, D., Mulvania, T., Pezzutto, A., Craxton, A. and Clark, E. A., Differential role for p38 mitogen-activated protein kinase in regulating CD40-induced gene expression in dendritic cells and B cells. J. Immunol. 1999. 163: 5786-5795.
7. Lu, H. T., Yang, D. D., Wysk, M., Gatti, E.. Mellman, I., Davis, R. J. and Flavell, R. A., Defective IL-12 production in mitogen-activated protein (MAP) kinase kinase 3 (Mkk3)-deficient mice. EMBO J. 1999. 18: 1845-1857.
8. Schulz, O., Edwards, A., Schito, M., Aliberti, J., Manickasingham, S, Sher A. and Reis e Sousa, C., CD40 triggering of heterodimeric IL-12 p70 production by dendritic cells in vivo requires a microbial priming signal. Immunity 2000. 13: 453-462.
9. Inaba, K., Turley, S., Iyoda, T., Yamaide, F., Shimoyama, S., Reis e Sousa, C., Germain, R. N., Mellman, I. and Steinman, R. M., The formation of immunogenic major histocompatibility complex class II- peptide ligands in lysosomal compartments of dendritic cells is regulated by inflammatory stimuli. J. Exp. Med. 2000. 191: 927-936.
10. Vidalain, P. O., Azocar, O., Servet-Delprat, C., Rabourdin-Combe, C., Gerlier, D. and Manie, S., CD40 signaling in human dendritic cells is initiated within membrane rafts. EMBO J. 2000. 19: 3304-3313.
11. + T cell functions. J. Exp. Med. 1996. 183: 2209-2218.
12. Bachmann, M. F., Wong, B. R., Josien, R., Steinman, R. M., Oxenius, A. and Choi, Y., TRANCE, a tumor necrosis factor family member critical for CD40 ligand-independent T helper cell activation. J. Exp. Med. 1999. 189: 1025-1031.
13. Whitmire, J. K., Flavell, R. A., Grewal, I. S., Larsen, C. P., Pearson, T. C. and Ahmed, R., CD40-CD40 ligand costimulation is required for generating antiviral CD4 T cell responses but is dispensable for CD8 T cell responses. J. Immunol. 1999. 163: 3194-3201.
14. Lu, Z., Yuan, L., Zhou, X., Sotomayor, E., Levitsky, H. I. and Pardoll, D. M., CD40-independent pathways of T cell help for priming of CD8(+) cytotoxic T lymphocytes. J. Exp. Med. 2000. 191: 541-550.
15. Scaria, A., St George, J. A., Gregory, R. J., Noelle, R. J., Wadsworth, S. C., Smith, A. E. and Kaplan, J. M., Antibody to CD40 ligand inhibits both humoral and cellular immune responses to adenoviral vectors and facilitates repeated administration to mouse airway. Gene Ther. 1997. 4: 611-617.
16. Miga, A. J., Masters, S. R., Durell, B. G., Gonzalez, M., Jenkins, M. K., Maliszewski, C., Kikutani, H., Wade, W. F. and Noelle, R. J., Dendritic cell longevity and T cell persistence is controlled by CD154-CD40 interactions. Eur. J. Immunol. 2001. 31: 959-965.
17. + T cells requires CD154 expression by Th cells in acute graft versus host disease. J. Immunol. 1999. 162: 4373-4376.
18. Trinchieri, G., Interleukin-12: a cytokine at the interface of inflammation and immunity. Adv. Immunol. 1998. 70: 83-243.
19. Wong, B. R., Josien, R., Lee, S. Y., Sauter, B., Li, H. L., Steinman, R. M. and Choi, Y., TRANCE (tumor necrosis factor [TNF]-related activation-induced cytokine), a new TNF family member predominantly expressed in T cells, is a dendritic cell-specific survival factor. J. Exp. Med. 1997. 186: 2075-2080.
20. Josien, R., Li, H. L., Ingulli, E., Sarma, S., Wong, B. R., Vologodskaia, M., Steinman, R. M. and Choi, Y., TRANCE, a tumor necrosis factor family member, enhances the longevity and adjuvant properties of dendritic cells in vivo. J. Exp. Med. 2000. 191: 495-502.
21. Kuhne, M. R., Robbins, M., Hambor, J. E., Mackey, M. F., Kosaka, Y., Nishimura, T., Gigley, J. P., Noelle, R. J. and Calderhead, D. M., Assembly and regulation of the CD40 receptor complex in human B cells. J. Exp. Med. 1997. 186: 337-342.
22. Hostager, B. S., Catlett, I. M. and Bishop, G. A., Recruitment of CD40 and tumor necrosis factor receptor-associated factors 2 and 3 to membrane microdomains during CD40 signaling. J. Biol. Chem. 2000. 275: 15392-15398.
23. Grammer, A. C. and Lipsky, P. E., CD40-mediated regulation of immune responses by TRAF-dependent and TRAF- independent signaling mechanisms. Adv. Immunol 2000. 76: 61-178.
24. Baud, V., Liu, Z. G., Bennett, B., Suzuki, N., Xia, Y. and Karin, M., Signaling by proinflammatory cytokines: oligomerization of TRAF2 and TRAF6 is sufficient for JNK and IKK activation and target gene induction via an amino-terminal effector domain. Genes Dev. 1999. 13: 1297-1308.
25. Wong, B. R., Besser, D., Kim, N., Arron, J. R., Vologodskaia, M., Hanafusa, H. and Choi, Y., TRANCE, a TNF family member, activates Akt/PKB through a signaling complex involving TRAF6 and c-Src. Mol. Cell. 1999. 4: 1041-1049.
26. Inoue, J., Ishida, T., Tsukamoto, N., Kobayashi, N., Naito, A., Azuma, S. and Yamamoto, T., Tumor necrosis factor receptor-associated factor (TRAF) family: adapter proteins that mediate cytokine signaling. Exp. Cell Res 2000. 254: 14-24.
27. Arron, J. R., Vologodskaia, M., Wong, B. R., Naramura, M., Kim, N., Gu, H. and Choi, Y., A positive regulatory role for Cbl family proteins in tumor necrosis factor-related activation-induced cytokine (trance) and CD40L-mediated Akt activation. J. Biol. Chem. 2001. 276: 30011-30017.
28. Hostager, B. S., Hsing, Y., Harms, D. E. and Bishop, G. A., Different CD40-mediated signaling events require distinct CD40 structural features. J. Immunol. 1996. 157: 1047-1053.
29. Hsing, Y., Hostager, B. S. and Bishop, G. A., Characterization of CD40 signaling determinants regulating nuclear factor-kappa B activation in B lymphocytes. J. Immunol. 1997. 159: 4898-4906.
30. Goldstein, M. D. and Watts, T. H., Identification of distinct domains in CD40 involved in B7-1 induction or growth inhibition. J. Immunol. 1996. 157: 2837-2843.
31. Pullen, S. S., Dang, T. T., Crute, J. J. and Kehry, M. R., CD40 signaling through tumor necrosis factor receptor-associated factors (TRAFs). Binding site specificity and activation of downstream pathways by distinct TRAFs. J. Biol. Chem. 1999. 274: 14246-14254.
32. Leo, E., Welsh, K., Matsuzawa, S., Zapata, J. M., Kitada, S., Mitchell, R. S., Ely, K. R. and Reed, J. C., Differential requirements for tumor necrosis factor receptor-associated factor family proteins in CD40-mediated induction of NF-kappaB and Jun N-terminal kinase activation. J. Biol. Chem. 1999. 274: 22414-22422.
33. Jalukar, S. V., Hostager, B. S. and Bishop, G. A., Characterization of the roles of TNF receptor-associated factor 6 in CD40-mediated B lymphocyte effector functions. J. Immunol. 2000. 164: 623-630.
34. Pullen, S. S., Labadia, M. E., Ingraham, R. H., McWhirter, S. M., Everdeen, D. S., Alber, T., Crute, J. J. and Kehry, M. R., High-affinity interactions of tumor necrosis factor receptor-associated factors (TRAFs) and CD40 require TRAF trimerization and CD40 multimerization. Biochemistry 1999. 38: 10168-10177.
35. Revy, P., Geissmann, F., Debre, M., Fischer, A. and Durandy, A., Normal CD40-mediated activation of monocytes and dendritic cells from patients with hyper-IgM syndrome due to a CD40 pathway defect in B cells. Eur. J. Immunol. 1998. 28: 3648-3654.
36. Langenkamp, A., Messi, M., Lanzavecchia, A. and Sallusto, F., Kinetics of dendritic cell activation: impact on priming of TH1, TH2 and nonpolarized T cells. Nat. Immunol. 2000. 1: 311-316.
37. Manning, E., Pullen, S. S., Souza, D. J., Kehry, M. and Noelle, R. J., Cellular responses to murine CD40 in a mouse B cell line may be TRAF dependent or independent. Eur. J. Immunol. 2002. 32: 39-49.
38. Babik, J. M., Adams, E., Tone, Y., Fairchild, P. J., Tone, M. and Waldmann, H., Expression of murine IL-12 is regulated by translational control of the p35 subunit. J. Immunol. 1999. 162: 4069-4078.
39. Hostager, B. S. and Bishop, G. A., Cutting edge: contrasting roles of TNF receptor-associated factor 2 (TRAF2) and TRAF3 in CD40-activated B lymphocyte differentiation. J. Immunol. 1999. 162: 6307-6311.
40. Nakano, H., Sakon, S., Koseki, H., Takemori, T., Tada, K., Matsumoto, M., Munechika, E., Sakai, T., Shirasawa, T., Akiba, H., Kobata, T., Santee, S. M., Ware, C. F., Rennert, P. D., Taniguchi, M., Yagita, H. and Okumura, K., Targeted disruption of Traf5 gene causes defects in CD40- and CD27-mediated lymphocyte activation. Proc. Natl. Acad. Sci. USA 1999. 96: 9803-9808.
41. Lee, S. Y., Reichlin, A., Santana, A, Sokol, K. A., Nussenzweig, M. C. and Choi, Y., TRAF2 is essential for JNK but not NF-kappaB activation and regulates lymphocyte proliferation and survival. Immunity 1997. 7: 703-713.
42. Nguyen, L. T., Duncan, G. S., Mirtsos, C., Ng, M., Speiser, D. E., Shahinian, A., Marino, M. W., Mak, T. W., Ohashi, P. S. and Yeh, W. C., TRAF2 deficiency results in hyperactivity of certain TNFR1 signals and impairment of CD40-mediated responses. Immunity 1999. 11: 379-389.
43. Lomaga, M. A., Yeh, W. C., Sarosi, I., Duncan, G. S., Furlonger, C., Ho, A., Morony, S., Capparelli, C., Van, G., Kaufman, S., van der Heiden, A., Itie, A., Wakeham, A., Khoo, W., Sasaki, T., Cao, Z., Penninger, J. M., Paige, C. J., Lacey, D. L., Dunstan, C. R., Boyle, W. J., Goeddel, D. V. and Mak, T. W., TRAF6 deficiency results in osteopetrosis and defective interleukin-1, CD40, and LPS signaling. Genes Dev. 1999. 13: 1015-1024.
44. Garceau, N., Kosaka, Y., Masters, S., Hambor, J., Shinkura, R., Honjo, T. and Noelle, R. J., Lineage-restricted function of nuclear factor kappaB-inducing kinase (NIK) in transducing signals via CD40. J. Exp. Med. 2000. 191: 381-386.
45. +, and double-negative Peyer's patch dendritic cells. J. Immunol 2001. 166: 4884-4890.
46. Vieira, P. L., de Jong, E. C., Wierenga, E. A., Kapsenberg, M. L. and Kalinski, P., Development of Th1-inducing capacity in myeloid dendritic cells requires environmental instruction. J. Immunol. 2000. 164: 4507-4512.
47. Lois, C., Refaeli, Y., Qin, X. F. and Van Parijs, L., Retroviruses as tools to study the immune system. Curr. Opin. Immunol 2001. 13: 496-504.
48. Ory, D. S., Neugeboren, B. A. and Mulligan, R. C., A stable human-derived packaging cell line for production of high titer retrovirus/vesicular stomatitis virus G pseudotypes. Proc. Natl. Acad. Sci. USA 1996. 93: 11400-11406.
49. Inui, S., Kaisho, T., Kikutani, H., Stamenkovic, I., Seed, B., Clark, E. A. and Kishimoto, T., Identification of the intracytoplasmic region essential for signal transduction through a B cell activation molecule, CD40. Eur. J. Immunol 1990. 20: 1747-1753.